Table 3 Comparison of patients receiving the REACH-HF intervention at the Beacon Sites between June 2019 and June 2020, those recruited into the REACH-HF trial and the general heart failure population recorded in the NACR database between June 2019 and June 2020 (excluding Beacon Sites patients)
Beacon sites (n = 132, unless specified otherwise) | Trial data-treatment arm (n = 96**, unless specified otherwise) | Heart failure patients recorded in the NACR for the same period (excluding Beacon Site patients) (n = 5549) | |
|---|---|---|---|
Age in years – mean (SD) | 75.6 (11.1) | 70.1 (10.4) | 68.8 (12.7) |
Male sex—n (%*) | 86 (66.2) | 74 (77.1) | 3860 (69.6) |
Ethnic group—n (%) | White 81 (90) | White 91 (94.8) | White 3935 (83.5) |
Non-white 9 (10) | Other/Black/Asian ethnic group 5 (5.2) | BAME 780 (16.5) | |
Accommodation status/marital status—n (%) | Single 29 (35.8) | Living alone 25 (26.1) | Single 1081 (28.9) |
Married/living with a partner 52 (64.2) | Living with a partner and/or a family member 71 (73.9) | Married/living with a partner 2664 (71.1) | |
Employment status—n (%) | Employed 5 (7.8) | Employed 15 (15.6) | Employed 546 (16.3) |
Unemployed/retired 59 (92.2) | Unemployed/retired 81 (84.4) | Unemployed/retired 2798 (83.7) | |
Mean MLHFQ at baseline (SD, n) | 36.1 (22.7, 50) | 31.4 (22.8, 96) | |
Mean HADS (depression) at baseline (SD, n) | 6.4 (5, 23) | 4.1 (3.3, 96) | 5.5 (4, 2761) |
Mean HADS (anxiety) at baseline (SD, n) | 7.2 (5.2, 23) | 4.7 (4.1, 96) | 5.9 (4.5, 2762) |
Mean ISWT at baseline (SD, n) | 190 (119.4, 13) | 274.7 (153.7, 90) | |
Heart failure status (NYHA) – n (%) | |||
Class I | 2 (5.9) | 22 (22.9) | 217 (22.3) |
Class II | 23 (67.6) | 57 (59.4) | 494 (50.7) |
Class III | 9 (26.5) | 17 (17.7) | 211 (21.6) |
Class IV | – | – | 53 (5.4) |